ARGET ATRP 与ROP 结合制备pH 响应两亲性聚合物分子刷及其自组装研究

结合电子转移活化剂再生-原子转移自由基聚合(ARGET ATRP)和开环聚合(ROP)法合成了一种具有无规疏水/ pH 响应结构的两亲性聚合物分子刷聚(甲基丙烯酸聚丙交酯酯-co-甲基丙烯酸)-b-聚甲基丙烯酸单甲氧基聚乙二醇酯 [P(PLAMA-co-MAA)-b-PPEGMA]. 通过核磁共振氢谱(¹H NMR)和凝胶渗透色谱(GPC)表征了聚合物的结构、分子量及分子量分布. 优化了反应条件并合成出分子量可控、分子量分布窄的聚合产物. 采用动态光散射法(DLS)、扫描电子显微镜(SEM)研究了聚合物分子刷在水溶液中自组装胶束的粒径、形貌及pH 响应行为. P(PLAMA-co-MAA)-b-PPEGMA 自组装形成粒径分布均匀的球形胶束. 且随着溶液pH 值从7 降低至3, 胶束中的PMAA 逐渐去离子化, 溶胀的胶束逐渐收缩, 粒径由200～300 nm 减小至150 nm 左右; 但当pH 值减小到2 以下, 胶束表面电荷量非常小, 胶束聚集, 使得粒径增大.     

一种新型聚酰亚胺-氨酯反渗透复合膜材料的合成及表征

采用关键功能单体N,N'-二甲基间苯二胺(DMMPD)和多元酰氯5-氯甲酰氧基-异肽酰氯(CFIC)聚合制备了一种耐氧化的聚酰亚胺-氨酯(DMMPD-CFIC)反渗透复合膜材料. 研究了水相溶剂、 多元胺浓度和组成及两相接触时间等因素对DMMPD聚合成膜的影响. 结果表明, 虽然DMMPD-CFIC膜的脱盐率不够理想, 但将4-甲基间苯二胺(MMPD)与DMMPD以2∶1(质量比)组合后制得的MMPD/DMMPD-CFIC膜的脱盐率得到显著提高, 并且对膜的耐氯性能影响不大. 采用傅里叶衰减全反射红外光谱(FTIR)和X射线光电子能谱(XPS)分析了2种膜的活性层的结构, 并利用扫描电镜(SEM)和原子力显微镜(AFM)对膜的表面形态进行了表征.     

Dynamic Behavior of Surfactants in Solution

Adsorption of various surfactants at the gas liquid interface is studied with equilibrium and dynamic surface tension measurements. The Wilhelmey plate method and maximum bubble pressure method are used for this study. Dynamic surface tension of solutions of different surfactants, sodium lauryl sulfate (SLS), polyoxyethylene glycol 4‐tert‐octyl phenyl ether (Triton X 100), poly‐oxyethylene(20) cetyl ether (Brij 58), and tetraethylene glycol mono‐n‐dodecyl ether (Brij 30), is measured at different concentrations. Adsorption of different surfactants is compared on the basis of equilibrium and dynamic behavior. Effectiveness and efficiency of different surfactants is found from equilibrium surface tension measurement. A new parameter is defined to quantify the dynamic behavior of adsorption, which gives the concentration of surfactant needed to reduce surface tension to half of its maximum reduction within a defined time available for adsorption. The dynamics of surfactant solution is quantified by using this parameter.     

两亲性接枝共聚物在选择性溶剂中自组装行为的模拟研究

利用粗粒化分子动力学(CGMD)方法研究了两亲性接枝共聚物在不同选择性溶剂中的自组装行为. 分析了主链刚性及链长对自组装结构的影响. 研究结果表明, 当溶剂对主链为良溶剂而对支链为不良溶剂时, 两亲性接枝共聚物随主链刚性的增加自组装形成花状胶束、 花桥状胶束及桥状胶束, 并且组分比例对自组装结构影响很大; 随着链长的增加, 柔性链出现单花状胶束到多花状胶束的转化. 当溶剂对主链为不良溶剂而对支链为良溶剂时, 可得到近球形或椭球形核壳状胶束及束状结构; 不同链长时, 柔性接枝共聚物链均只能得到近球形的单核壳状胶束.     

光散射法研究丙烯酸十八酯和苯乙烯微乳液 共聚机理

在十六烷基溴化吡啶/叔丁醇/15%丙烯酸十八酯和苯乙烯/水体系的O/W微乳液中,使用动态光散射法,研究其中两种单体共聚反应的成核机理。结果表明,聚合过程中乳胶粒成核位置主要在增溶胶囊的单体微珠中,乳胶粒主要依靠单体微珠不断提供单体而长大。     

稳态荧光探针法测定临界胶束聚集数

以芘为荧光探针、二苯甲酮为猝灭剂,用稳态荧光探针法测定了SDS和AS的胶束聚集数(Nm).以芘的饱和水溶液为溶剂配制表面活性剂溶液,二苯甲酮的适宜浓度取小于1.00 mmol•L－1时,可以获得满意的实验结果.当表面活性剂溶液浓度为5～9倍cmc时,Nm随表面活性剂浓度增大而线性增大,而随温度的变化略有波动.cSAA=cmc时,Nm值为一本征值,定义为临界胶束聚集数[Nm].[Nm]值可从Nm－cSAA实验曲线外延得到.25℃时SDS的临界胶束聚集数[Nm]为57;40℃时SDS的[Nm]为49,AS的[Nm]为55.     

Circumvent PEGylation dilemma by implementing matrix metalloproteinase-responsive chemistry for promoted tumor gene therapy

Surface modification by poly(ethylene glycol) (PEGylation) has been acknowledged as a powerful strategy in minimizing non-specific reactions for biomedical devices. Once applied into manufacture of drug/gene delivery systems, PEGylation has demonstrated to significantly improve their biocompatibility and stealthiness in physiological environment. Nonetheless, reluctant cell membrane affinities thus cellular uptake efficiencies owing to PEGylation brought up further issues that are imperative to be resolved. Pertain to this PEGylation dilemma, we attempted to introduce peptide (GPLGVRG) linkage between block copolymer of PEG-poly{N'-[N-(2-aminoethyl)-2-aminoethyl]aspartamide} PAsp(DET), wherein the cationic PAsp(DET) could self-assemble with pDNA into nanoscaled complex core. Noteworthy was the peptide linkage whose amino acids sequence could be specifically recognized and degraded by matrix metalloproteinases (MMPs) (overexpressed in extracellular milieu of tumors). Therefore, our subsequent studies validated facile detachment of PEGylation from the aforementioned polyplex micelles upon treatment of MMPs, which elicited improved cytomembrane affinities and cellular uptake efficiencies. In addition, promoted escape from endosome entrapment was also confirmed through direct endosome membrane destabilization by PAsp(DET), which was further elucidated to be attributable to dePEGylation as well as elevated charged density of PAsp(DET) in acidic endosomes. These benefits from dePEGylation eventually contributed to promoted gene expression at the affected cells and potent tumor growth suppression based on anti-angiogenic approach. Therefore, our developed strategy has provided a facile approach in overcoming the dilemma of PEGylation, which could be informative in design of drug/gene delivery systems.     

Micellization and mixed micellization of cationic gemini (dimeric) surfactants and cationic conventional (monomeric) surfactants: Conductometric,dye solubilization,and surface tension studies

In the present study, we have investigated the self-association, mixed micellization, and thermodynamic studies of a cationic gemini (dimeric) surfactant, hexanediyl-1,6-bis(dimethylcetylammonium bromide (16-6-16)) and a cationic conventional (monomeric) surfactant, cetyltrimethylammonium bromide (CTAB). The critical micelle concentration (CMC) of pure (16-6-16 and CTAB) and mixed (16-6-16+CTAB) surfactants was measured by electrical conductivity, dye solubilization, and surface tension measurements. The surface properties (viz., C₂₀ (the surfactant concentration required to reduce the surface tension by 20 mN/m), Π_CMC (the surface pressure at the CMC), Γ_max (maximum surface excess concentration at the air/water interface), A_min (the minimum area per surfactant molecule at the air/water interface), etc.) of micellar (16-6-16 or CTAB) and mixed micellar (16-6-16+CTAB) surfactant systems were evaluated. The thermodynamic parameters of the micellar (16-6-16 and CTAB) and mixed micellar (16-6-16+CTAB) surfactant systems were also evaluated.     

Optimization of Biocompatibility for a Hydrophilic Biological Molecule Encapsulation System

Despite considerable advances in recent years, challenges in delivery and storage of biological drugs persist and may delay or prohibit their clinical application. Though nanoparticle-based approaches for small molecule drug encapsulation are mature, encapsulation of proteins remains problematic due to destabilization of the protein. Reverse micelles composed of decylmonoacyl glycerol (10MAG) and lauryldimethylamino-N-oxide (LDAO) in low-viscosity alkanes have been shown to preserve the structure and stability of a wide range of biological macromolecules. Here, we present a first step on developing this system as a future platform for storage and delivery of biological drugs by replacing the non-biocompatible alkane solvent with solvents currently used in small molecule delivery systems. Using a novel screening approach, we performed a comprehensive evaluation of the 10MAG/LDAO system using two preparation methods across seven biocompatible solvents with analysis of toxicity and encapsulation efficiency for each solvent. By using an inexpensive hydrophilic small molecule to test a wide range of conditions, we identify optimal solvent properties for further development. We validate the predictions from this screen with preliminary protein encapsulation tests. The insight provided lays the foundation for further development of this system toward long-term room-temperature storage of biologics or toward water-in-oil-in-water biologic delivery systems.     

带有可调通道的嵌段共聚物胶束对药物的控制释放

用聚丙烯酸叔丁酯-b-聚乙二醇(PtBA45-b-PEG114)和聚丙烯酸叔丁酯-b-聚4-乙烯基吡啶(PtBA60-b-P4VP80)制备了复合胶束. 该胶束在pH=2.5的酸性水溶液中形成以PtBA为核, PEG和P4VP为壳的稳定球型结构. 在pH=12时, 壳层的P4VP链段变为疏水, 塌缩在PtBA的核上形成内壳, PEG链段继续保持溶解状态, 与成核的PtBA连接并穿过塌陷的P4VP内壳, 形成胶束的冠, 由于PEG处于溶解状态, 其分子链间有比较大的空隙, 可以控制一些小分子通过, 在胶束的表面形成通道. 该通道类似于生物膜的蛋白通道, 可以控制PtBA核与外界进行能量或物质交换的速度. 以布洛芬为模型分子, 负载在胶束内进行药物控制释放研究的结果表明, 胶束表面的通道可以起到明显控制布洛芬释放速度的作用, 并且药物的释放速度与通道在胶束表面的比例成正比.